The wellness industry often promotes quick fixes that address symptoms rather than underlying causes. Super Patch takes a different approach, challenging the assumption that external products are always needed. Instead, it focuses on optimizing communication between the brain and the body. This approach suggests that disrupted signaling, not simply a lack of external intervention, can be at the root of many problems.
The Problem with the Status Quo
Many conventional solutions push the body toward specific outcomes. While medications and supplements can be effective in certain contexts, they may not address underlying causes, leaving some individuals seeking longer-term improvements, especially for issues like sleep, balance, and focus.
Super Patch views these challenges as possible nervous system communication issues. Improving signal processing may help the body respond more effectively.
A Personal Mission Turned Company
Jay Dhaliwal founded Super Patch after his mother was diagnosed with Multiple Sclerosis in 1983. With limited treatments available, he sought ways to support the body without relying only on pharmaceuticals.
This effort led to Vibrotactile Trigger Technology (VTT), which is based on neuroscience and sensory signaling.
The company now operates in several countries. Growth has come mainly through direct-to-consumer sales and practitioner support.
How the Technology Works
Super Patch products are adhesive skin patches with textured surfaces that contain no active chemicals. They stimulate mechanical receptors, nerve endings in the skin that sense touch.
When these receptors are stimulated, they send signals through peripheral nerves to the central nervous system. VTT is designed to deliver specific, common, repeatable patterns of stimulation that the brain may interpret as sensory input. This process is comparable to how tactile systems such as Braille convey information through patterned touch.
The intended effect is to prompt the nervous system to adjust certain responses. However, outcomes can vary depending on the individual and the context of use.
Evidence and Adoption
Research on vibrotactile stimulation has been published in journals such as Frontiers in Neuroscience and the Journal of NeuroEngineering and Rehabilitation, particularly on balance, gait, and sensory feedback.
Super Patch states that its products have been evaluated in clinical settings, but the amount of published, peer-reviewed research specific to its proprietary technology remains limited. Publicly available studies supporting product outcomes are few, so some claims should be interpreted with caution.
The company reports a large user base and growing practitioner interest, including from physical therapists and chiropractors. However, there is limited independent data available to verify adoption rates or to support clinical endorsements objectively.
A Different Perspective on Wellness
Super Patch advocates a wellness model that targets internal sensory input rather than external chemical fixes, highlighting a deliberate shift from treating symptoms to addressing potential communication issues within the nervous system.
For individuals exploring alternatives or complementary options, technologies based on touch and sensory signaling may offer another area to consider. As with any wellness product, outcomes depend on individual conditions, and consultation with qualified professionals remains important.
